Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistance, Multiple, Bacterial”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Not applicableStudy completedNCT06760143
What this trial is testing

Antibiotic Prophylaxis in Lung-Transplant Recipients

Who this might be right for
Lung-transplant RecipientsAntibiotic Prophylaxis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 90
Testing effectiveness (Phase 2)Study completedNCT07496502
What this trial is testing

Effect of Oral Microbiota on MDRO Decolonization

Who this might be right for
Clostridioides Difficile InfectionDrug Resistance, BacterialGastrointestinal Microbiome+2 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 42
Large-scale testing (Phase 3)Looking for participantsNCT04188743
What this trial is testing

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)

Who this might be right for
Resistance Bacterial
University Hospital, Ghent 150
Not applicableStudy completedNCT07425561
What this trial is testing

Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

Who this might be right for
PneumoniaPneumonia - BacterialMulti Drug Resistant+5 more
Azienda Ospedaliero-Universitaria Careggi 300
Post-approval studies (Phase 4)Looking for participantsNCT07477119
What this trial is testing

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Who this might be right for
LinezolidTuberculosis Multi Drug Resistant ActiveTherapeutic Drug Monitoring (TDM)
Marco Schiuma 150
Not applicableStudy completedNCT04574596
What this trial is testing

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

Who this might be right for
E Coli Infection
Duke University 300
Not applicableStudy completedNCT03137875
What this trial is testing

Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis

Who this might be right for
TuberculosisMulti Drug Resistant Tuberculosis
Epicentre 122
Not applicableUnknownNCT01208519
What this trial is testing

SATURN 04 Nosocomial Acquisition Study

Who this might be right for
Bacterial ResistanceInfection Resistant to Multiple DrugsStaph Aureus Methicillin Resistant Colonization+1 more
Catholic University of the Sacred Heart 16,680
Early research (Phase 1)Ended earlyNCT01863719
What this trial is testing

Aerosolized and Intravenous Colistin in Healthy Adults

Who this might be right for
Pathogen ResistancePneumococcal InfectionPneumonia
National Institute of Allergy and Infectious Diseases (NIAID) 27
Large-scale testing (Phase 3)Study completedNCT00509106
What this trial is testing

Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia

Who this might be right for
Bacterial Pneumonia
Forest Laboratories 622
Large-scale testing (Phase 3)Looking for participantsNCT07486024
What this trial is testing

Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

Who this might be right for
MDR-TBTuberculosis Multi Drug Resistant ActiveAntibiotic Resistance+1 more
Assistance Publique - Hôpitaux de Paris 55
Not applicableNot Yet RecruitingNCT06700577
What this trial is testing

Multidrug Resistance in Newly Diagnosed TB Patient

Who this might be right for
Tuberculosis
Assiut University 100
Early research (Phase 1)Study completedNCT04309656
What this trial is testing

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Who this might be right for
Multi-drug Resistant Tuberculosis
Global Alliance for TB Drug Development 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT07503600
What this trial is testing

The Effect of Adjunctive Melatonin With Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections

Who this might be right for
Multidrug-Resistant Gram-Negative Bacterial InfectionsAntimicrobial Resistance
Ain Shams University 70
Not applicableStudy completedNCT02729532
What this trial is testing

Effect of Xpert MTB/RIF on Patient Outcomes

Who this might be right for
Tuberculosis
University of North Carolina, Chapel Hill 776
Not applicableNot Yet RecruitingNCT07505446
What this trial is testing

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Who this might be right for
Multi Drug Resistant OrganismsAntibiotic Resistance
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT02607449
What this trial is testing

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Who this might be right for
Tuberculosis, MDR
Scientific Center for Anti-infectious Drugs, Kazakhstan 344
Not applicableUnknownNCT00676754
What this trial is testing

Epidemiology of MDR-TB in Peru

Who this might be right for
TB Multi-drug Resistant
Harvard University Faculty of Medicine 18,544
Not applicableUnknownNCT04397536
What this trial is testing

New Genomic Techniques and Management of Multidrug-resistant Tuberculosis

Who this might be right for
Multi-Drug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 172
Next Page